SEC filing · 8-K

Lifecore Biomedical, Inc. DE: Material agreement

Lifecore Biomedical extended its contract manufacturing agreement with Alcon through 2034.

Filed September 29, 2026

Positive for the company

What happened

On September 24, 2026, Lifecore Biomedical entered into a third amendment to its contract manufacturing agreement with Alcon Research, effective November 1, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Lifecore Biomedical, Inc. DE

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.